Friday, September 8, 2023

NovaCure Tumor Treating Field Phase III LUNAR trial in non-small cell lung cancer, leading to significant and clinically meaningful improvements in OS when used in conjunction with standard of care.

Although their recent Phase III Ovarian cancer trail failed,  the Phase III LUNAR trial in non-small cell lung cancer, leading to significant and clinically meaningful improvements in OS when used in conjunction with standard of care.

Link to article 

No comments:

Post a Comment